Silence Therapeutics
在场
Silence Therapeutics 是一家在股票代码 SLN (GB) 下上市的公司。
高管
查看带有其 15 名主要高管的组织结构图
Silence Therapeutics 搜索最多的简介
- Craig Tooman, President and Chief Executive Officer
- Alistair Gray, Non-Executive Director
- Ian Ross, Non-Executive Chairman of the Board
高管在Silence Therapeutics变化
- Marie Wikström Lindholm 曾任 Senior Vice President and Head of Molecular Design, 现升职为 Chief Scientific Officer (新闻发布的2023十二月3号).
- Curtis Rambaran 曾任 Vice President and Head of Clinical Science, 现升职为 Chief Medical Officer (新闻发布的2023十二月3号).
创建提醒
跟踪 Silence Therapeutics 的高管变动
药店
Silence Therapeutics 拥有 1,861 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- MedMen has filed for bankruptcy protection (公布2024四月28号).
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
药店 行业的其他推荐联系人
消息
Silence Therapeutics 的最新新闻稿
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
- Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
- Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
- Silence Therapeutics Reports Second Quarter 2023 Results
- Silence Therapeutics | Press Coverage
通过电子邮件
